Cargando…
Characterisation of P2Y receptor subtypes mediating vasodilation and vasoconstriction of rat pulmonary artery using selective antagonists
Pulmonary vascular tone is modulated by nucleotides, but which P2 receptors mediate these actions is largely unclear. The aim of this study, therefore, was to use subtype-selective antagonists to determine the roles of individual P2Y receptor subtypes in nucleotide-evoked pulmonary vasodilation and...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9832182/ https://www.ncbi.nlm.nih.gov/pubmed/36018534 http://dx.doi.org/10.1007/s11302-022-09895-x |
_version_ | 1784868006652805120 |
---|---|
author | Dales, Markie O. Mitchell, Callum Gurney, Alison M. Drummond, Robert M. Kennedy, Charles |
author_facet | Dales, Markie O. Mitchell, Callum Gurney, Alison M. Drummond, Robert M. Kennedy, Charles |
author_sort | Dales, Markie O. |
collection | PubMed |
description | Pulmonary vascular tone is modulated by nucleotides, but which P2 receptors mediate these actions is largely unclear. The aim of this study, therefore, was to use subtype-selective antagonists to determine the roles of individual P2Y receptor subtypes in nucleotide-evoked pulmonary vasodilation and vasoconstriction. Isometric tension was recorded from rat intrapulmonary artery rings (i.d. 200–500 µm) mounted on a wire myograph. Nucleotides evoked concentration- and endothelium-dependent vasodilation of precontracted tissues, but the concentration–response curves were shallow and did not reach a plateau. The selective P2Y(2) antagonist, AR-C118925XX, inhibited uridine 5′-triphosphate (UTP)- but not adenosine 5′-triphosphate (ATP)-evoked relaxation, whereas the P2Y(6) receptor antagonist, MRS2578, had no effect on UTP but inhibited relaxation elicited by uridine 5′-diphosphate (UDP). ATP-evoked relaxations were unaffected by the P2Y(1) receptor antagonist, MRS2179, which substantially inhibited responses to adenosine 5′-diphosphate (ADP), and by the P2Y(12/13) receptor antagonist, cangrelor, which potentiated responses to ADP. Both agonists were unaffected by CGS1593, an adenosine receptor antagonist. Finally, AR-C118925XX had no effect on vasoconstriction elicited by UTP or ATP at resting tone, although P2Y(2) receptor mRNA was extracted from endothelium-denuded tissues using reverse transcription polymerase chain reaction with specific oligonucleotide primers. In conclusion, UTP elicits pulmonary vasodilation via P2Y(2) receptors, whereas UDP acts at P2Y(6) and ADP at P2Y(1) receptors, respectively. How ATP induces vasodilation is unclear, but it does not involve P2Y(1), P2Y(2), P2Y(12), P2Y(13), or adenosine receptors. UTP- and ATP-evoked vasoconstriction was not mediated by P2Y(2) receptors. Thus, this study advances our understanding of how nucleotides modulate pulmonary vascular tone. |
format | Online Article Text |
id | pubmed-9832182 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Netherlands |
record_format | MEDLINE/PubMed |
spelling | pubmed-98321822023-01-12 Characterisation of P2Y receptor subtypes mediating vasodilation and vasoconstriction of rat pulmonary artery using selective antagonists Dales, Markie O. Mitchell, Callum Gurney, Alison M. Drummond, Robert M. Kennedy, Charles Purinergic Signal Original Article Pulmonary vascular tone is modulated by nucleotides, but which P2 receptors mediate these actions is largely unclear. The aim of this study, therefore, was to use subtype-selective antagonists to determine the roles of individual P2Y receptor subtypes in nucleotide-evoked pulmonary vasodilation and vasoconstriction. Isometric tension was recorded from rat intrapulmonary artery rings (i.d. 200–500 µm) mounted on a wire myograph. Nucleotides evoked concentration- and endothelium-dependent vasodilation of precontracted tissues, but the concentration–response curves were shallow and did not reach a plateau. The selective P2Y(2) antagonist, AR-C118925XX, inhibited uridine 5′-triphosphate (UTP)- but not adenosine 5′-triphosphate (ATP)-evoked relaxation, whereas the P2Y(6) receptor antagonist, MRS2578, had no effect on UTP but inhibited relaxation elicited by uridine 5′-diphosphate (UDP). ATP-evoked relaxations were unaffected by the P2Y(1) receptor antagonist, MRS2179, which substantially inhibited responses to adenosine 5′-diphosphate (ADP), and by the P2Y(12/13) receptor antagonist, cangrelor, which potentiated responses to ADP. Both agonists were unaffected by CGS1593, an adenosine receptor antagonist. Finally, AR-C118925XX had no effect on vasoconstriction elicited by UTP or ATP at resting tone, although P2Y(2) receptor mRNA was extracted from endothelium-denuded tissues using reverse transcription polymerase chain reaction with specific oligonucleotide primers. In conclusion, UTP elicits pulmonary vasodilation via P2Y(2) receptors, whereas UDP acts at P2Y(6) and ADP at P2Y(1) receptors, respectively. How ATP induces vasodilation is unclear, but it does not involve P2Y(1), P2Y(2), P2Y(12), P2Y(13), or adenosine receptors. UTP- and ATP-evoked vasoconstriction was not mediated by P2Y(2) receptors. Thus, this study advances our understanding of how nucleotides modulate pulmonary vascular tone. Springer Netherlands 2022-08-26 2022-12 /pmc/articles/PMC9832182/ /pubmed/36018534 http://dx.doi.org/10.1007/s11302-022-09895-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Dales, Markie O. Mitchell, Callum Gurney, Alison M. Drummond, Robert M. Kennedy, Charles Characterisation of P2Y receptor subtypes mediating vasodilation and vasoconstriction of rat pulmonary artery using selective antagonists |
title | Characterisation of P2Y receptor subtypes mediating vasodilation and vasoconstriction of rat pulmonary artery using selective antagonists |
title_full | Characterisation of P2Y receptor subtypes mediating vasodilation and vasoconstriction of rat pulmonary artery using selective antagonists |
title_fullStr | Characterisation of P2Y receptor subtypes mediating vasodilation and vasoconstriction of rat pulmonary artery using selective antagonists |
title_full_unstemmed | Characterisation of P2Y receptor subtypes mediating vasodilation and vasoconstriction of rat pulmonary artery using selective antagonists |
title_short | Characterisation of P2Y receptor subtypes mediating vasodilation and vasoconstriction of rat pulmonary artery using selective antagonists |
title_sort | characterisation of p2y receptor subtypes mediating vasodilation and vasoconstriction of rat pulmonary artery using selective antagonists |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9832182/ https://www.ncbi.nlm.nih.gov/pubmed/36018534 http://dx.doi.org/10.1007/s11302-022-09895-x |
work_keys_str_mv | AT dalesmarkieo characterisationofp2yreceptorsubtypesmediatingvasodilationandvasoconstrictionofratpulmonaryarteryusingselectiveantagonists AT mitchellcallum characterisationofp2yreceptorsubtypesmediatingvasodilationandvasoconstrictionofratpulmonaryarteryusingselectiveantagonists AT gurneyalisonm characterisationofp2yreceptorsubtypesmediatingvasodilationandvasoconstrictionofratpulmonaryarteryusingselectiveantagonists AT drummondrobertm characterisationofp2yreceptorsubtypesmediatingvasodilationandvasoconstrictionofratpulmonaryarteryusingselectiveantagonists AT kennedycharles characterisationofp2yreceptorsubtypesmediatingvasodilationandvasoconstrictionofratpulmonaryarteryusingselectiveantagonists |